Organometallics
Article
together. The mixture was stirred at room temperature for at least 3 h,
filtered, and then lyophilized. 13 (10.8 mg, 7.80 μmol, 94.6% yield)
was formed as a yellow, pentane-soluble powder, although impurities
can give it a green color. Crystals were obtained by allowing a pentane
suspension of AgPF6 (8.1 mg, 32 μmol) was added. The mixture was
allowed to stir for one hour before being pumped down. It was then
redissolved in a small amount of benzene and filtered. The solution
was then layered with pentane and allowed to sit overnight. Dark blue
needle-like crystals of 16·2C6H6 (39.1 mg, 30.4 μmol, 94.1% yield)
1
solution to evaporate. H NMR (300 MHz, CD2Cl2): δ 0.90 (s, 18H,
1
2 t-Bu on ligand phenolate), 1.15 (s, 9H, t-Bu on ligand pyridine), 1.28
were recovered. H NMR (300 MHz, CD2Cl2): δ −3.1 (very broad),
4
(s, 18H, 2 t-Bu on ligand phenolate), 6.52 (d, 2H, J = 2.6 Hz, ligand
−2.0 (broad), 0.73, 3.99, 12.0 (very broad). 19F{13C} NMR (282
phenolate aryl), 6.70 (s, 2H, ligand pyridine aryl), 6.96 (d, 2H, 4J = 2.5
Hz, ligand phenolate aryl), 7.08 (br s, 12H, triphenylphosphines), 7.21
(br s, 12H, triphenylphosphines), 8.16 (br s, 6H, triphenylphos-
phines). 13C{1H} NMR (126 MHz, CD2Cl2): δ 30.3, 30.4, 31.8, 34.3,
34.9, 35.7, 120.5, 124.8, 125.1, 126.6, 127.4 (br), 129.8 (br), 133.7
(br), 136.9, 137.3 (br), 141.2, 154.8, 159.2, 170.4. 31P{1H} NMR (122
MHz, C6D6): δ −29.1. MS FAB+: 1386.5627 (M+), 1123.3712
([Ir(PPh3)(ONOtBu)(I)]+).
MHz, CD2Cl2): δ −73.8 (d, JP−F = 710 Hz). 31P{1H} NMR (122
1
1
MHz, CD2Cl2): δ −144.7 (septet, JP−F = 710 Hz). MS FAB+:
985.5561 (M+), 867.4697 ([Ir(PEt3)(ONOtBu)(Me)]+).
Synthesis of (ONOtBu)Ir(PPh3)2Ph, 17. 12 (20.4 mg, 16.0 μmol)
was dissolved in 10 mL of benzene and stirred in a 65 °C oil bath for
24 h. The solution was reintroduced into the glovebox, and the solvent
was removed. The residue was redissolved in pentane and filtered, and
the solution pumped down to obtain 17 (20.9 mg, 15.6 μmol, 98%
yield). Crystals were obtained by allowing a pentane solution to
Synthesis of (ONOtBu)Ir(PEt3)2Me, 14. 12 (79.4 mg, 62.3 μmol)
was dissolved in 5 mL of benzene, and PEt3 (20 μL, 136 μmol) was
added. The solution was allowed to stir for seven hours, after which
the benzene and excess PEt3 were removed by lyophilization. The
yellow powder obtained was redissolved in 5 mL of dichloromethane,
and [Rh(cod)2]OTf (30.5 mg, 62.7 μmol) dissolved in 3 mL of
acetonitrile was added to complex residual PEt3. The solution was
allowed to stir for three hours. Afterward, it was pumped down, and
the resulting 14 was redissolved in hexanes, filtered to remove the
byproducts and impurities, and pumped down again. Isolated yield was
51.4 mg (52.2 μmol, 83.7%). Crystals were obtained by allowing a
pentane solution to evaporate. 1H NMR (300 MHz, C6D6): δ 0.75 (m,
18H, 6 P-CH2-CH3), 1.16 (s, 9H, t-Bu on ligand pyridine), 1.46 (s,
18H, 2 t-Bu on ligand phenolate), 1.65 (m, 33H, 2 t-Bu on ligand
1
evaporate. H NMR (300 MHz, CD2Cl2): δ 0.70 (s, 18H, 2 t-Bu on
ligand phenolate), 1.20 (s, 9H, t-Bu on ligand pyridine), 1.43 (s, 18H,
2 t-Bu on ligand phenolate), 5.83 (br s, 2H, iridium phenyl), 6.54 (br s,
4
1H, iridium phenyl), 6.62 (d, 2H, J = 2.7 Hz, ligand phenolate aryl),
6.78 (s, 2H, ligand pyridine aryl), 6.8−7.1 (multiple broad peaks, 30H,
triphenylphosphines), 7.16 (d, 2H, 4J = 2.6 Hz, ligand phenolate aryl),
7.29 (br s, 2H, iridium phenyl). 13C{1H} NMR (126 MHz, C6D6): δ
30.3, 30.6, 32.2, 34.2, 34.4, 35.9, 120.4, 123.6, 124.1, 125.6, 125.9,
126.9, 127.0, 129.6, 129.7, 133.3 (br), 135.7, 136.5 (br), 141.2, 145.9,
155.3, 157.7, 171.5. 31P{1H} NMR (122 MHz, CD2Cl2): δ −13.2.
Reaction of 12 with Toluene. 12 (7.8 mg, 6.1 μmol) was
dissolved in 700 μL of toluene-d8 in a J-Young NMR tube. The tube
1
was heated at 65 °C and periodically monitored by H NMR until all
4
phenolate, 6 P-CH2-CH3, iridium methyl), 7.34 (d, 2H, J = 2.6 Hz,
starting material signals had disappeared, which took six days; the final
1H NMR spectrum was complex. The mass spectrum of the solid
obtained by evaporation exhibited a signal indicating the presence of
the analogous tolyl complex (1094.5436, [Ir(PPh3)(ONOtBu)-
(C6D4CD3]+, [M − PPh3]+), while the 31P{1H} NMR of the dissolved
solid showed two approximately equal signals at δ −12.2 and −12.3,
tentatively assigned to meta and para isomers. A much weaker signal at
−12.8 may indicate formation of a very small amount of ortho isomer.
Isolation of a pure product was not achieved.
ligand phenolate aryl), 7.43 (s, 2H, ligand pyridine aryl), 7.53 (d, 2H,
4J = 2.6 Hz, ligand phenolate aryl). 13C{1H } NMR (126 MHz, C6D6):
δ −33.4 (t, JC−P = 8.2 Hz), 8.1 (t, JC−P = 1.5 Hz), 13.3 (t, JC−P = 14.3
Hz), 30.6, 31.3, 32.4, 34.4, 35.3, 36.3, 118.7, 124.0, 125.6, 128.1, 136.2,
140.6, 156.3, 159.3, 172.9 (t, J = 2.2 Hz). 31P{1H} NMR (122 MHz,
C6D6): δ −19.2. MS FAB+: 985.5609 (M+), 867.4800 ([Ir(PEt3)-
(ONOtBu)(Me)]+). Anal. Calcd for C50H84IrNO2P2: C, 60.95; H, 8.59;
N, 1.42. Found: C, 61.18; H, 8.32; N, 1.45.
Synthesis of (ONOtBu)Ir(PEt3)2I, 15. 14 (11.8 mg, 12.0 μmol)
and I2 (3.0 mg, 12.0 μmol) were each dissolved in benzene and mixed
together. The mixture was stirred at room temperature for 5 h, filtered,
and then lyophilized. 15 was formed as a yellow, pentane-soluble
powder. Crystals were obtained by allowing a pentane solution to
Synthesis of (ONOtBu)Ir(PPh3)[κ2-(o-C6H4)PPh2], 18. 12 (8.2
mg, 6.4 μmol) was dissolved in 1 mL of CD2Cl2 in a J-Young NMR
tube and submerged in a 65 °C oil bath for 21 h. After NMR
confirmation that the reaction was complete, the solvent was removed
to obtain 18 (7.7 mg, 6.1 μmol, 95% isolated yield). Crystals were
1
1
evaporate. H NMR (300 MHz, C6D6): δ 0.74 (m, 18H, 6 P-CH2-
obtained by allowing a pentane solution to evaporate. H NMR (500
CH3), 1.09 (s, 9H, t-Bu on ligand pyridine), 1.42 (s, 18H, 2 t-Bu on
ligand phenolate), 1.71 (s, 18H, 2 t-Bu on ligand phenolate), 1.96 (m,
12H, 6 P-CH2-CH3), 7.36 (s, 2H, ligand pyridine aryl), 7.37 (d, 2H,
MHz, CD2Cl2): δ 0.47 (s, 18H, 2 t-Bu on ligand phenolate), 1.27 (s,
18H, 2 t-Bu on ligand phenolate), 1.34 (s, 9H, tBu on ligand pyridine),
6.64 (m, 4H, triphenylphosphines), 6.9−7.4 (many multiplets, 23H,
triphenylphosphines), 7.50 (dd, 3J = 4.4 Hz, 3J = 6.6 Hz, 2H,
triphenylphosphines). 13C{1H} NMR (126 MHz, CD2Cl2): δ 29.58,
30.76, 32.11, 34.24, 35.27, 35.32, 119.51, 119.69, 122.48, 122.55,
123.83, 124.00, 125.60, 125.77, 128.32, 128.39, 129.03, 129.54, 133.76,
133.83, 136.03, 139.93, 140.51, 140.61, 152.80, 153.23, 154.77, 159.36,
4
4J = 2.5 Hz, ligand phenolate aryl), 7.46 (d, 2H, J = 2.5 Hz, ligand
phenolate aryl). 13C{1H } NMR (126 MHz, C6D6): δ 8.4 (t, JC−P = 1.6
Hz), 15.0 (t, JC−P = 15.3 Hz), 30.0, 31.0, 31.9, 34.1, 34.9, 35.8, 118.8,
124.5, 124.7, 126.5, 137.2, 141.3, 156.3 (t, JC−P = 1.4 Hz), 159.9, 171.7
(t, JC−P = 2.2 Hz). 31P{1H} NMR (122 MHz, C6D6): δ −26.3.
The reaction of 14 and I2 in dichloromethane gives a new species
along with 15 and MeI; over the course of four days all of the 15 is
converted to the new species. Crystals were obtained after the contents
of the NMR tube were allowed to evaporate. X-ray crystallography,
NMR, and MS support identification of this compound as the
analogous chloride, (ONOtBu)Ir(PEt3)2Cl. 1H NMR (300 MHz,
CD2Cl2): δ 0.74 (m, 18H, 6 P-CH2-CH3), 1.01 (m, 12H, 6 P-CH2-
CH3), 1.33 (s, 18H, 2 t-Bu on ligand phenolate), 1.37 (s, 18H, 2 t-Bu
on ligand phenolate), 1.38 (s, 9H, t-Bu on ligand pyridine), 7.11 (d,
2H, 4J = 2.5 Hz, ligand phenolate aryl), 7.26 (d, 2H, 4J = 2.5 Hz, ligand
phenolate aryl), 7.31 (s, 2H, ligand pyridine aryl). 13C{1H } NMR
(126 MHz, CD2Cl2): δ 7.7, 13.0 (t, JC−P = 15.1 Hz), 30.5, 30.6, 31.9,
34.4, 35.5, 35.9, 119.4, 124.6, 124.8, 126.6, 137.6, 140.3, 157.0, 160.5,
171.7. 31P{1H} NMR (122 MHz, CD2Cl2): δ −20.7. MS FAB+
970.5417 ([Ir(PEt3)2(ONOtBu)]+), 887.3802 ([Ir(PEt3)(ONOtBu)-
(Cl)]+), 852.4370 ([Ir(PEt3)(ONOtBu)]+).
2
170.44. 31P{1H} NMR (122 MHz, CD2Cl2): δ −69.5 (d, JP−P = 448
Hz), −2.5 (d, 2JP−P = 448 Hz). MS FAB+: 1257.5292 (M+), 995.4405
([Ir(PPh3)(ONOtBu)]+).
Synthesis of [(ONOtBu)Ir(PPh3)(CH2CN)]2, 19. 12 (13.1 mg, 10.3
μmol) was dissolved in 1 mL of CD2Cl2 in a J-Young NMR tube, and
40 μL of acetonitrile was added. The tube was then submerged in a 65
°C oil bath for 72 h. After NMR confirmation that the reaction had
completed, [Rh(cod)2]OTf (2.6 mg, 5.3 μmol) dissolved in 1 mL of
acetonitrile was added. The solution was allowed to stir for three
hours. Afterward, it was pumped down, and the resulting 19 was
redissolved in hexanes, filtered to remove the byproducts and
impurities, and pumped down again. Crystals were obtained by
allowing a pentane solution to evaporate. Isolated yield was 91% (9.7
mg, 4.7 μmol). 1H NMR (500 MHz, CD2Cl2): δ 1.23 (s, 9H, 2 t-Bu on
ligand), 1.25 (s, 9H, 2 t-Bu on ligand), 1.43 (s, 9H, 2 t-Bu on ligand),
1.44 (s, 9H, 2 t-Bu on ligand), 1.55 (s, 9H, 2 t-Bu on ligand), 1.87
(s, 2H, Ir-CH2-CN), 6.4−6.5 (m, 3H, triphenylphosphine), 6.7−6.8
(m, 3H, triphenylphosphine), 6.9−7.1 (m, 6H, triphenylphosphine),
Synthesis of [(ONOtBu)Ir(PEt3)2Me]PF6, 16. 14 (31.8 mg, 32.3
μmol) was dissolved in dichloromethane, and a dichloromethane
6764
dx.doi.org/10.1021/om201069k | Organometallics 2011, 30, 6751−6765